Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07TKZ
|
|||
Former ID |
DNCL002838
|
|||
Drug Name |
BIOD-123
|
|||
Indication | Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Phase 2 | [1] | |
Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 2 | [2] | ||
Company |
Biodel
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01686620) A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog). U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.